Cargando…
Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion
BACKGROUND: Tumour markers in pleural fluid and their diagnostic value are subject to debate. Although there are several studies on this topic, standardized cut-off values do not exist. In this study we investigated the potential of a ratio of carcinoembryonic antigen (CEA) in pleural fluid and seru...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535745/ https://www.ncbi.nlm.nih.gov/pubmed/31205509 http://dx.doi.org/10.1177/1758835919850341 |
_version_ | 1783421620813037568 |
---|---|
author | Hackner, Klaus Errhalt, Peter Handzhiev, Sabin |
author_facet | Hackner, Klaus Errhalt, Peter Handzhiev, Sabin |
author_sort | Hackner, Klaus |
collection | PubMed |
description | BACKGROUND: Tumour markers in pleural fluid and their diagnostic value are subject to debate. Although there are several studies on this topic, standardized cut-off values do not exist. In this study we investigated the potential of a ratio of carcinoembryonic antigen (CEA) in pleural fluid and serum, serving as an individual marker for pleural cancer manifestation. METHODS: A total of 201 consecutive patients with unclear pleural effusion were included in the study; 98 were diagnosed with malignant pleural effusion and 103 had an effusion due to other, benign reasons. CEA levels in pleural fluid and serum were measured. RESULTS: By using receiver operating characteristics analysis, at the cut-off of 1.0, the CEA ratio showed a specificity of 92% and sensitivity of 85%, with a positive predictive value of 91% and a negative predictive value of 87%. These results are higher than in previous investigations on different pleural tumour markers and their combination. CONCLUSIONS: The CEA ratio is a useful tool in predicting pleural carcinosis. Elevated results in cytology-negative patients should lead to further investigations, such as repeated cytological examination or thoracoscopy. |
format | Online Article Text |
id | pubmed-6535745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-65357452019-06-14 Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion Hackner, Klaus Errhalt, Peter Handzhiev, Sabin Ther Adv Med Oncol Original Research BACKGROUND: Tumour markers in pleural fluid and their diagnostic value are subject to debate. Although there are several studies on this topic, standardized cut-off values do not exist. In this study we investigated the potential of a ratio of carcinoembryonic antigen (CEA) in pleural fluid and serum, serving as an individual marker for pleural cancer manifestation. METHODS: A total of 201 consecutive patients with unclear pleural effusion were included in the study; 98 were diagnosed with malignant pleural effusion and 103 had an effusion due to other, benign reasons. CEA levels in pleural fluid and serum were measured. RESULTS: By using receiver operating characteristics analysis, at the cut-off of 1.0, the CEA ratio showed a specificity of 92% and sensitivity of 85%, with a positive predictive value of 91% and a negative predictive value of 87%. These results are higher than in previous investigations on different pleural tumour markers and their combination. CONCLUSIONS: The CEA ratio is a useful tool in predicting pleural carcinosis. Elevated results in cytology-negative patients should lead to further investigations, such as repeated cytological examination or thoracoscopy. SAGE Publications 2019-05-22 /pmc/articles/PMC6535745/ /pubmed/31205509 http://dx.doi.org/10.1177/1758835919850341 Text en © The Author(s), 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Hackner, Klaus Errhalt, Peter Handzhiev, Sabin Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion |
title | Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion |
title_full | Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion |
title_fullStr | Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion |
title_full_unstemmed | Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion |
title_short | Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion |
title_sort | ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535745/ https://www.ncbi.nlm.nih.gov/pubmed/31205509 http://dx.doi.org/10.1177/1758835919850341 |
work_keys_str_mv | AT hacknerklaus ratioofcarcinoembryonicantigeninpleuralfluidandserumforthediagnosisofmalignantpleuraleffusion AT errhaltpeter ratioofcarcinoembryonicantigeninpleuralfluidandserumforthediagnosisofmalignantpleuraleffusion AT handzhievsabin ratioofcarcinoembryonicantigeninpleuralfluidandserumforthediagnosisofmalignantpleuraleffusion |